State Street SPDR標普生技ETF XBI 深 滬
等待開盤 09-26 09:30:00 美东时间
155.03
-1.020
-0.65%
華盛通- 最 高157.17
- 今 開156.80
- 成交量 823.56万股
- 最 低 153.8522
- 昨 收 156.05
- 總市值 1023.20万
- 52周最高 169.89
- 市盈率 靜 --
- 換手率 12478.25%
- 52周最低 102.0053
- 委 比 70.94%
- 總股本 6.60万
- 歷史最高 174.017
- 量 比 0.78
- 振 幅 2.13%
- 歷史最低 42.5447
- 每 手 1
- 風險率 17.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多期权异动 | META一看跌期权成交量2.17万张，该期权跌43.12%
SPX的看跌期权成交量260.88万张，看涨期权成交量217.23万张，看跌/看涨交易量比率约1.20，表明投资者押注该指数看跌意愿较强。
09-16 09:04
Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data
Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.
05-27 22:06
Moderna's Legal Hit Steals Spotlight From Strong Sales
MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth and new flu vaccine approvals in 2026.
05-01 22:44
Tech Leads, Dow Lags As Oil Holds Near $92: What's Moving Markets Wednesday?
U.S. stocks were mixed at midday Wednesday as tech stocks rallied while industrials dragged the Dow lower. Oil held above $90 and yields ticked higher, reflecting lingering geopolitical risk.
04-16 01:16
Citigroup, Morgan Stanley, CBRE Group And More On CNBC's 'Final Trades'
Experts predict higher stock prices for CBRE Group and Morgan Stanley, while State Street SPDR S&P Biotech ETF and Citigroup are recommended.
04-14 20:05
Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfolio. Get the deal details here.
04-06 20:13
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress
BridgeBio Pharma shares Phase 3 trial update, but early data show progress for rare muscle disease treatment.
03-12 19:47
美股盘后 | VERTIV HOLDINGS LLC涨5.47%，Corebridge Financial, Inc.涨4.34%
VERTIV HOLDINGS LLC涨5.47%；Corebridge Financial, Inc.涨4.34%；回声星通信涨4.00%
03-07 07:11
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars
Moderna's mRNA-1010 flu vaccine clears FDA review, with stock rising ahead of major approvals.
02-19 02:20
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
PTC Therapeutics, Inc. (PTCT) stock closed lower following the withdrawal of its New Drug Application for Translarna by the FDA.
02-13 19:18
